H.C. Wainwright Sticks to Its Buy Rating for Anixa Biosciences (ANIX)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report) on February 14 and set a price target of ...
Stoke Therapeutics price target raised to $47 from $35 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Stoke Therapeutics (STOK) to $47 from $35 and keeps a Buy rating on the shares. Stoke and ...
What is HC Wainwright’s Forecast for AnaptysBio Q1 Earnings?
Research analysts at HC Wainwright dropped their Q1 2025 EPS estimates for AnaptysBio in a research report issued on ...
Q1 Earnings Forecast for Rezolute Issued By HC Wainwright
Analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Rezolute in a research report issued on ...
Largo Resources stock target cut to $3.70 at H.C. Wainwright
H.C. Wainwright adjusted its price target for Largo Resources Ltd. (NASDAQ:LGO) to $3.70, down from the previous $4.20, while maintaining a "Buy" rating on the stock. The firm's decision follows Largo ...
HC Wainwright maintains $18 target on Enanta shares, affirms Buy
H.C. Wainwright reiterated a Buy rating and a price target of $18.00 on Enanta Pharmaceuticals (NASDAQ:ENTA) shares, significantly above the current price of $4.90. The stock is trading near its ...
Morningstar22d
H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker
Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement, and At-the-Market (ATM) Offerings H.C. Wainwright & Co., LLC, announced its #1 Ranking ...